A detailed history of Private Capital Group, LLC transactions in Invitae Corp stock. As of the latest transaction made, Private Capital Group, LLC holds 269 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
269
Previous 269 -0.0%
Holding current value
$0
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

BUY
$6.28 - $15.59 $1,676 - $4,162
267 Added 13350.0%
269 $2,000
Q4 2021

Jan 24, 2022

SELL
$14.7 - $28.67 $1,146 - $2,236
-78 Reduced 97.5%
2 $0
Q3 2021

Oct 13, 2021

BUY
$24.31 - $33.6 $48 - $67
2 Added 2.56%
80 $2,000
Q1 2021

Apr 12, 2021

BUY
$33.06 - $56.93 $2,578 - $4,440
78 New
78 $3,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.